Entrepreneurs continue to invest in Brazil's medical marijuana market, despite a lack of support from Brazil's government. There is no legislation in favor of legalizing medical marijuana in Brazil, and the government disapproved of the National National Health Surveillance Agency's proposal to regulate the issue.
The medical marijuana market is projected to reach R$ 1.1 billion (US$ 269 million) to R$ 4.7 billion (US$ 1.1 billion) per year, according to studies.
The most enthusiastic projection predicts that the country will have at least 3.9 million patients who could be treated with cannabis.
Since 2014, over 4,000 patients have been authorized to import products made from the active cannabidiol (CBD) and tetrahydrocannabinol (THC) for the treatment of conditions such as epilepsy, anxiety disorders, depression, and multiple sclerosis.
João Pessoa (PB) has the only patient association to have a court order to grow marijuana and produce medicinal oil.
In two and a half years, the Abrace Esperança entity saw the number of patients increase from 155 to 2,500. They pay annuities of R$ 350 and values ranging from R$ 150 to R$ 200 for oil - which represents 10% of the cost of imported.
Translated by Kiratiana Freelon